Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between 18 and 75 years old (male or female)
- People who have had surgery to remove colorectal cancer for the first time, within the last two months, where lab results after surgery confirmed the cancer was at stage IIB, IIC, or III
- People with a general health and activity level rated as 0, 1, or 2 on a standard medical scale (meaning able to care for oneself, with varying levels of activity limitation) (confirm with trial site)
- People with no history of any other cancer
- People who are willing to participate, sign a consent form, and work with the research team to provide information
Who may not be able to join:
- People who have existing heart conditions, stroke-related conditions, lung disease, severe high blood pressure, or diabetes that is not well controlled
- People who have a confirmed infection following their surgery
- People who have experienced complications from their colorectal cancer surgery, or who are still recovering from the effects of the surgery
- People who have syphilis or other infections that can be spread through blood
- People who are pregnant or breastfeeding, or women who could become pregnant and are not using contraception
- People who are already taking certain traditional Chinese medicines with similar effects to the study medicine, including compound Banmao capsule, Huachansu capsule, Kangai Injection, or Pingxiao tablets
- People with a mental illness, or any other condition the research team considers makes participation unsuitable
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xishan Wang, Professor, Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phone: +0086-13552367779
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Disease-Free Survival(DFS); Overall survival(OS); Local recurrence-Free Survival rate; Distant Metastasis-Free Survival rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.